Ibex Wealth Advisors Merck & Co., Inc. Transaction History

Ibex Wealth Advisors

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $633,979 - $680,888	5,121 New	5,121 $633,000
Q4 2023 Jan 29, 2024	BUY	$100.18 - $109.02 $300 - $327	3 New	3 $366,000
Q4 2021 Feb 22, 2022	SELL	$72.28 - $90.54 $72,280 - $90,540	-1,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $71,680 - $78,830	1,000 New	1,000 $75,000
Q2 2020 Aug 14, 2020	SELL	$70.42 - $80.13 $3.54 Million - $4.03 Million	-50,271 Closed	0 $0
Q1 2020 May 05, 2020	BUY	$63.36 - $87.82 $208,897 - $289,542	3,297 Added 7.02%	50,271 $3.87 Million
Q4 2019 Jan 24, 2020	BUY	$77.58 - $87.54 $273,779 - $308,928	3,529 Added 8.12%	46,974 $4.27 Million
Q3 2019 Nov 12, 2019	BUY	$76.08 - $82.93 $3.16 Million - $3.44 Million	41,497 Added 2130.24%	43,445 $3.66 Million
Q2 2019 Jul 30, 2019	BUY	$69.84 - $81.59 $136,048 - $158,937	1,948 New	1,948 $163,000
Q1 2018 Jun 13, 2018	SELL	$50.96 - $59.23 $320,334 - $372,319	-6,286 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $1.35 Million - $1.61 Million	-26,144 Reduced 80.62%	6,286 $356,000
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $1.9 Million - $2.05 Million	32,430	32,430 $2.09 Million

3,824

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $257B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Ibex Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Ibex Wealth Advisors with notifications on news.